These findings were further supported by ex vivo analysis of isolated CD8+ T cells from the tumor, which revealed higher levels of granzyme B and perforin release (Fig. 8L, M) upon exposure to SIINFEKL peptide, while isolated splenic CD8+ T cells reached significantly higher levels (Fig. 8N). The gene discussed is CD8A; the disease is neoplasm.